Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by QContinuum1on May 17, 2024 7:11am
136 Views
Post# 36044904

Notice

Notice
Notice how the chatter on the board is over a totally immaterial and nonsensical item like the Hope facility.  I mean, fine, liquidate if it's not being used but honestly, I don't much care, not even a little.  Will it help with operating costs, sure, but this kind of decision is what you'd expect ANY mature leadership team to make  so really, again, who cares.

What everyone should be focusing on is SP and why it isn't moving and what leadership should be doing to make it move.  A share buyback is the only meaningful immediate term thing they could do to make existing shareholders very happy while at the same time announcing that this business is the real deal and ready to make hay.  Keeping the power dry for another aquisition is NOT what this business needs right now.  If we're shuttering a GMP plant in BC, capacity is clearly not an issue.  So the effort would be about buying revenue, which is fine, but this business isn't mature enough yet.  Wanna be Biovail, I'm good with that, but the SP needs to appreciate and immediately for this team to continue to have my trust.

I don't expect LABS to follows necessarily with the ebbs and flows of the sector, but I do expect it to slowly sawtooth itself up over time, like the dumpster fire Canopy has been able to do.  If they can, why not LABS?
<< Previous
Bullboard Posts
Next >>